← The Wire
MGNXNasdaq
MACROGENICS INC
Pharmaceutical Preparations · DE · CIK 1125345
Develops antibody-based cancer therapeutics, including ADCs and multi-specific antibodies
$252M
Market cap
$4.86
Last close
+1.0%
1D
+6.1%
5D
1.4M
Volume
Price · last 39 sessions+51.9%
May 4L $2.94 · H $4.86Jun 29
270
Total filings
May 20, 2026
Last filing
12/31
Fiscal year end
DEF 14ADEF 14AApr 8, 2026DEF 14ADEF 14AApr 11, 2025DEF 14ADEF 14AApr 8, 2024DEF 14ADEF 14AApr 17, 2023DEF 14ADEF 14AApr 8, 2022DEF 14ADEF 14AApr 2, 2021DEF 14ADEF 14AApr 3, 2020DEF 14ADEF 14AApr 5, 2019DEF 14ADEFINITIVE PROXY STATEMENTApr 6, 2018DEF 14ADEF 14AApr 4, 2017DEF 14ADEF 14AApr 7, 2016DEF 14ADEF 14AApr 9, 2015DEF 14ADEF 14AApr 30, 2014
Similar companies
Comparable business profile · signals at a glance